3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Burkitt Lymphoma
15
Lymphoma, Large B-Cell, Diffuse
7
Precursor Cell Lymphoblastic Leukemia-Lymphoma
6
Prostatic Neoplasms
5
Precursor T-Cell Lymphoblastic Leukemia-Lymphoma
4
Leukemia, Biphenotypic, Acute
4
Precursor B-Cell Lymphoblastic Leukemia-Lymphoma
3
Melanoma
2
Carcinoma, Merkel Cell
2
Carcinoma, Basal Cell
2
Plasmablastic Lymphoma
1
Multiple Myeloma
1
Lymphoma, T-Cell
1
Lymphoma, Follicular
1
Lymphoma, B-Cell, Marginal Zone
1
Lymphoma, B-Cell
1
Lymphoma, AIDS-Related
1
Lymphoma
1
Lugano Classification Limited Stage Hodgkin Lymphoma AJCC v8
1
Leukemia, Myeloid, Accelerated Phase
1
HTLV-I Infections
1
Down Syndrome
1
Blastic Plasmacytoid Dendritic Cell Neoplasm
1
Blast Crisis
1
Ann Arbor Stage II Mantle Cell Lymphoma
1
Interventions
Cyclophosphamide
15
fludarabine
12
Mycophenolic Acid
10
Standard of Care
9
Whole-Body Irradiation
7
Tacrolimus
7
venetoclax
6
Specimen Handling
6
Sirolimus
6
Practice Guidelines as Topic
6
trametinib
5
Melphalan
5
fludarabine phosphate
4
Mesna
4
Magnetic Resonance Spectroscopy
4
Filgrastim
4
Biopsy
4
Behavior Therapy
4
Azacitidine
4
Thiotepa
3
Peripheral Blood Stem Cell Transplantation
3
GSK2636771
3
Educational Status
3
Crizotinib
3
Busulfan
3
thymoglobulin
2
talquetamab
2
ruxolitinib
2
palbociclib
2
osimertinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Hematologic Neoplasms
×
deltacortene
×
90 days
×
Clear all
No trials found.